Nano X Imaging EBIT

As of the most recent data (June 2026), NNOX shows a EBIT of $-100M. That compares with $-58M in the prior-year period — down 75.0% year over year. That is below the Healthcare sector average of $110B. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, NNOX's EBIT is now $-100M (was $-58M) — a 75.0% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether Nano X Imaging is outperforming or lagging.

The Healthcare sector average EBIT is about $110B. Nano X Imaging is at $-100M, which is lower that average. That is roughly 100.1% below the sector mean. Use the comparison chart on this page to see how NNOX stacks up against individual peers as well.

Tracking NNOX's ebit over time shows whether Nano X Imaging is scaling, shrinking, or reshaping that part of the business. The current reading is $-100M That compares with $-58M in the prior-year period — down 75.0% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this ebit page, Stockcircle has Nano X Imaging's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect EBIT (currently $-100M) with ownership activity and broader fundamentals.